Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shanghai Henlius Biotechnology
Pharma
Akeso, AstraZeneca, Ono—Fierce Pharma Asia
Akeso's first OS data for its Keytruda challenger caused a violent market reaction. AstraZeneca disclosed another potential fine in China. And more.
Angus Liu
May 2, 2025 7:58am
Takeda, AZ-Daiichi, Fosun-Henlius—Fierce Pharma Asia
Jan 24, 2025 8:55am
Henlius Biotech shareholders reject proposed takeover by Fosun
Jan 22, 2025 12:09pm
Apellis hit with yet another eye drug snub in Europe
Sep 20, 2024 10:06am
Daiichi-Merck, Wegovy, Takeda CEO—Fierce Pharma Asia
Jun 28, 2024 8:40am
With big discounts, 100+ drugs win national coverage in China
Jan 18, 2023 2:30pm
